Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,800
Closed -$485K 6033
2025
Q1
$485K Buy
+20,800
New +$532K ﹤0.01% 4834
2019
Q4
Sell
-47,500
Closed -$1.31M 4366
2019
Q3
$1.31M Buy
+47,500
New +$1.26M ﹤0.01% 2701
2019
Q2
Sell
-85,000
Closed -$1.76M 4190
2019
Q1
$1.76M Hold
85,000
﹤0.01% 2499
2018
Q4
$1.72M Sell
85,000
-39,200
-32% -$821K ﹤0.01% 2284
2018
Q3
$2.67M Hold
124,200
﹤0.01% 2228
2018
Q2
$2.86M Buy
+124,200
New +$2.95M ﹤0.01% 2169
2014
Q1
Sell
-91,000
Closed -$1.5M 3619
2013
Q4
$1.5M Buy
+91,000
New +$1.33M ﹤0.01% 2027

Other funds holding GNTX

Israel Englander's GNTX Position: Q2 2026 in Review

Israel Englander reduced its Gentex (GNTX) stake by 86% in Q2 2026, selling an estimated $38.4M and leaving 259,260 shares worth $6.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

Israel Englander first reported a position in GNTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $78.1M in Q1 2018. 527 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Israel Englander held 259,260 shares of Gentex worth $6.55M as of Q2 2026.
  • Israel Englander sold 1,625,152 Gentex shares in Q2 2026, an estimated $38.4M.
  • Gentex made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2734 holding.
  • Israel Englander first reported a position in Gentex in Q2 2013 and has held it in 49 quarters since.
  • Israel Englander's Gentex position peaked at $78.1M in Q1 2018.
  • 527 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.